Merck Makes Big Move For Cancer Drug Developer

Merck is acquiring ArQule for $20 per share

Managing Editor
Dec 9, 2019 at 10:16 AM
facebook X logo linkedin

Drugmaker and blue chip Merck & Co, Inc. (NYSE:MRK) made a splash on the M&A front this morning, after acquiring Massachusetts-based cancer drug developer ArQule (ARQL) for $2.7 billion cash, or $20 per share. The deal implies a premium of 107% based on ARQL's Friday close of $9.66. Analysts have been quick to comment, with Cantor Fitzgerald calling it smart and strategic and SVB Leerink analyst Jonathan Chang claiming it will be "unlocking value for investors."

Nevertheless, Merck stock is down 0.3% to trade at $88.62, on track to snap a four-day winning streak that culminated in a nearly 19-year high of $89.24 on Friday. The shares have slowly and steadily carved out a channel of higher highs and lows in 2019, with recent support emerging at their 200-day moving average the last three months. 

Despite the ascension, options traders have been more bearish than usual toward Merck. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 10-day put/call volume ratio of 0.58 ranks in the elevated 75th annual percentile. So, while calls have outpaced puts on an absolute basis, the rate of put buying relative to call buying has been accelerated.

Options are certainly the right move for anyone looking to invest in the Dow stock. The security's Schaeffer's Volatility Index (SVI) of 15% sits in the 12th percentile of its annual range. This means short-term options are pricing in extremely low volatility expectations right now.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI